Loading…
●Research use only — not for human or veterinary use
Also known as Thymosin beta-4, Tβ4
A synthetic thymosin-β4 peptide studied in cellular and tissue-signaling research, where it is associated with actin regulation. Supplied as a documented reference standard.
TB-500 is associated with thymosin β4, a peptide studied for its role in actin sequestration and cytoskeletal dynamics. In research models it is examined in the context of cell migration and tissue-signaling pathways, as a reference tool for those mechanisms.
Thymosin β4 is a 43-residue peptide with a molecular weight of ~4,963.5 g/mol. Its size places it between small synthetic peptides and larger proteins, which informs both its synthesis route and its analytical handling.
TB-500 is studied within tissue & cellular signaling research and is frequently examined alongside BPC-157. Both sit in the broad cell- and tissue-signaling area of the encyclopedia.
As a lyophilised peptide it follows the standard cold, dry storage profile — see lyophilised peptide stability and cold-chain handling for temperature-sensitive shipments.
Lots are documented by HPLC purity and mass-spec identity; see the analytical verification workflow for the receive-and-verify procedure.
References to TB-500 here describe in-vitro and pre-clinical research only. It is supplied as a research-use-only reference standard, not for human or veterinary use.
Store lyophilised at -20 °C; reconstituted material at 2–8 °C within the analytical window.
Reconstituted purity tracked by HPLC over the storage window.
Research use only — All products and content are intended strictly for in-vitro laboratory research and analytical use. Not for human or veterinary use, not for consumption, and not for any diagnostic or therapeutic purpose.